Regarding their January ARCHIVES editorial, Rosenberg et al1 should take a similar and even stronger stance on government-funded clinical studies. As long as subject anonymity is protected, all study investigators and even the public should have complete and full access to all of the original and processed data from studies funded by the National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke, or any other governmental agency. The Freedom of Information Act guarantees and protects such rights.
Meyer MA. Full Access for Government-Funded Clinical Trials. Arch Neurol. 2002;59(10):1664. doi: